— Additional ‘Assay-Ready’ Controls for B.1.1.7 Now Available — SOUTH SAN FRANCISCO, Calif. —  Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its new synthetic RNA reference controls, which include the new variant strains […]

Eurofins (Paris:ERF) adds virus variant monitoring capabilities to its commercially available SARS-CoV-2 test portfolio. This new solution is part of the Eurofins COVID-19 Sentinel™ and SAFER@WORK™ programs which provide an early warning of the presence of SARS-CoV-2 amongst large populations or at a given site (e.g. a city, factories, education institutions, government and public service […]

London, UK – PCR Biosystems, the UK-based specialists in DNA and RNA analysis, have launched a range of IsoFast™ Bst Polymerase reagents for rapid, robust and sensitive DNA and RNA amplification. Through its nucleic acid strand displacement capabilities, Bst polymerase eliminates the need for the high temperature denaturation step associated with traditional Taq enzymes. This enables […]

New synthetic genomes of the UK and South Africa variants will accelerate discovery and development for vaccines and therapeutics San Diego — Codex DNA, Inc., today announced the release of the world’s first full-length synthetic genomes for two emerging variants of the SARS-CoV-2 virus. The new genomes include the B.1.1.7 variant that initially emerged in […]